INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹19 Cr | ₹11 Cr | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr |
What is the latest Operating Profit of INDO US BIOTECH ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹9.39 Cr |
| Mar2022 | ₹6.93 Cr |
| Mar2021 | ₹5.51 Cr |
How is Operating Profit of INDO US BIOTECH Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 75.26 | |
| Mar2024 | ₹11 Cr | 15.03 | |
| Mar2023 | ₹9.39 Cr | 35.52 | |
| Mar2022 | ₹6.93 Cr | 25.70 | |
| Mar2021 | ₹5.51 Cr | - | |
Compare Operating Profit of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹178.2 Cr | -1.5% | -6.8% | -42.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,717.7 Cr | 1.1% | 7.3% | -22.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,003.9 Cr | -0.1% | -1.5% | -10.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,090.2 Cr | 0.6% | 2.2% | 9.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹924.6 Cr | -0.2% | -8.2% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹553.7 Cr | 5% | 11.4% | 10.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.5% |
-6.8% |
-42.2% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses